Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Mayo Clinic
Mayo Clinic
Memorial Sloan Kettering Cancer Center
New York Medical College
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Baylor College of Medicine
FBD Biologics Limited
Dana-Farber Cancer Institute
Medical College of Wisconsin
St. Petersburg State Pavlov Medical University
University College, London
VIVUS LLC
City of Hope Medical Center
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Big Ten Cancer Research Consortium
Baylor College of Medicine
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Takeda
Indiana University
Canadian Cancer Trials Group
University of Miami
Fondazione Italiana Linfomi - ETS
Aurigene Discovery Technologies Limited
Mayo Clinic
Aurigene Discovery Technologies Limited
Baylor College of Medicine
Compass Therapeutics
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
Thomas Jefferson University
University of Utah
National Medical Research Radiological Centre of the Ministry of Health of Russia
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Miami
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
University of Wisconsin, Madison
National Research Center for Hematology, Russia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Murdoch Childrens Research Institute
Marker Therapeutics, Inc.
St. Petersburg State Pavlov Medical University
New York Medical College
Baylor College of Medicine
Baylor College of Medicine